IMMUNE-MEDIATED LUNG DISEASE

This adverse event was reported 1825 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED LUNG DISEASE:

# Drug Count
0 NIVOLUMAB 745
1 PEMBROLIZUMAB 686
2 IPILIMUMAB 385
3 CARBOPLATIN 375
4 PACLITAXEL 238
5 PACLITAXEL (AIBUMIN-BOUND) 230
6 PEMETREXED DISODIUM 200
7 PEMETREXED 156
8 DURVALUMAB 128
9 ATEZOLIZUMAB 108
See all common drugs associated with IMMUNE-MEDIATED LUNG DISEASE

IMMUNE-MEDIATED LUNG DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ENSITRELVIR 1 0.0556
1 SUNVOZERTINIB 1 0.0244
2 PENPULIMAB 1 0.0102
3 PAPAVERINE HYDROCHLORIDE 1 0.0098
4 IPILIMUMAB 385 0.0088
5 ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE 1 0.0086
6 DOSTARLIMAB 20 0.0080
7 LEVAMLODIPINE 1 0.0080
8 NIVOLUMAB 745 0.0076
9 TETRACAINE HYDROCHLORIDE 1 0.0075
See all drugs enriched for association with IMMUNE-MEDIATED LUNG DISEASE